 Vasil Peev
Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 5 | 2017 | 93 | 1.500 |
Why?
| | Kidney Failure, Chronic | 3 | 2019 | 175 | 0.850 |
Why?
| | Receptors, Urokinase Plasminogen Activator | 5 | 2019 | 82 | 0.810 |
Why?
| | Kidney Transplantation | 2 | 2021 | 144 | 0.750 |
Why?
| | Nephrology | 1 | 2016 | 16 | 0.630 |
Why?
| | Referral and Consultation | 1 | 2016 | 93 | 0.590 |
Why?
| | Podocytes | 6 | 2019 | 161 | 0.580 |
Why?
| | Dyslipidemias | 1 | 2014 | 24 | 0.540 |
Why?
| | Malnutrition | 1 | 2014 | 21 | 0.540 |
Why?
| | Proteinuria | 4 | 2019 | 111 | 0.520 |
Why?
| | Integrin alphaVbeta3 | 2 | 2019 | 26 | 0.370 |
Why?
| | Glomerulosclerosis, Focal Segmental | 2 | 2017 | 86 | 0.310 |
Why?
| | Kidney | 3 | 2021 | 209 | 0.280 |
Why?
| | Kidney Diseases | 2 | 2019 | 143 | 0.260 |
Why?
| | Glomerular Filtration Rate | 3 | 2019 | 75 | 0.250 |
Why?
| | Needles | 1 | 2021 | 18 | 0.220 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2021 | 25 | 0.220 |
Why?
| | Inducible T-Cell Co-Stimulator Ligand | 1 | 2019 | 7 | 0.200 |
Why?
| | Apolipoproteins | 1 | 2017 | 11 | 0.170 |
Why?
| | Lipoproteins, HDL | 1 | 2017 | 31 | 0.170 |
Why?
| | Myeloid Cells | 1 | 2016 | 20 | 0.170 |
Why?
| | Renal Replacement Therapy | 1 | 2016 | 23 | 0.160 |
Why?
| | Animals | 8 | 2019 | 5221 | 0.160 |
Why?
| | Diabetes Mellitus | 1 | 2017 | 140 | 0.160 |
Why?
| | Humans | 12 | 2021 | 30741 | 0.160 |
Why?
| | Mice | 5 | 2019 | 1843 | 0.140 |
Why?
| | Cathepsin L | 2 | 2011 | 15 | 0.130 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 75 | 0.130 |
Why?
| | Cytoskeletal Proteins | 1 | 2011 | 32 | 0.120 |
Why?
| | Inflammation | 1 | 2014 | 345 | 0.110 |
Why?
| | Mice, Transgenic | 3 | 2019 | 301 | 0.110 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2011 | 93 | 0.110 |
Why?
| | Mice, Knockout | 3 | 2019 | 384 | 0.110 |
Why?
| | Signal Transduction | 3 | 2019 | 582 | 0.090 |
Why?
| | Kidney Glomerulus | 2 | 2017 | 85 | 0.080 |
Why?
| | HEK293 Cells | 2 | 2019 | 87 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2019 | 831 | 0.070 |
Why?
| | Cohort Studies | 2 | 2021 | 1959 | 0.060 |
Why?
| | Transplant Recipients | 1 | 2021 | 18 | 0.060 |
Why?
| | Adult | 3 | 2021 | 9760 | 0.060 |
Why?
| | Pancreas | 1 | 2021 | 36 | 0.060 |
Why?
| | Retrospective Studies | 2 | 2021 | 3456 | 0.050 |
Why?
| | Biopsy, Needle | 1 | 2021 | 122 | 0.050 |
Why?
| | Middle Aged | 3 | 2021 | 11256 | 0.050 |
Why?
| | Equipment Design | 1 | 2021 | 204 | 0.050 |
Why?
| | Receptor, PAR-2 | 1 | 2019 | 4 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2019 | 20 | 0.050 |
Why?
| | Protein Multimerization | 1 | 2019 | 23 | 0.050 |
Why?
| | Adipocytes | 1 | 2019 | 25 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2019 | 59 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2019 | 100 | 0.050 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 298 | 0.050 |
Why?
| | Incidence | 1 | 2021 | 827 | 0.050 |
Why?
| | Biopsy | 1 | 2019 | 286 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2021 | 875 | 0.040 |
Why?
| | Surface Plasmon Resonance | 1 | 2017 | 9 | 0.040 |
Why?
| | Integrins | 1 | 2017 | 27 | 0.040 |
Why?
| | Albuminuria | 1 | 2017 | 23 | 0.040 |
Why?
| | Male | 3 | 2021 | 17552 | 0.040 |
Why?
| | Female | 3 | 2021 | 18107 | 0.040 |
Why?
| | Diabetic Nephropathies | 1 | 2017 | 39 | 0.040 |
Why?
| | Mice, SCID | 1 | 2016 | 64 | 0.040 |
Why?
| | Alleles | 1 | 2017 | 230 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 66 | 0.040 |
Why?
| | Adoptive Transfer | 1 | 2016 | 53 | 0.040 |
Why?
| | Genotype | 1 | 2017 | 447 | 0.040 |
Why?
| | Prospective Studies | 1 | 2021 | 1891 | 0.040 |
Why?
| | Hypertension | 1 | 2017 | 272 | 0.040 |
Why?
| | Aged | 2 | 2021 | 10156 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 473 | 0.040 |
Why?
| | Models, Biological | 1 | 2017 | 428 | 0.030 |
Why?
| | Disease Progression | 1 | 2017 | 851 | 0.030 |
Why?
| | Peptide Hydrolases | 1 | 2011 | 21 | 0.030 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2011 | 42 | 0.030 |
Why?
| | Cytoskeleton | 1 | 2011 | 66 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2021 | 3850 | 0.030 |
Why?
| | Cell Survival | 1 | 2011 | 182 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2011 | 361 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2011 | 172 | 0.030 |
Why?
| | Adolescent | 1 | 2017 | 2627 | 0.030 |
Why?
| | African Americans | 1 | 2017 | 780 | 0.030 |
Why?
| | Young Adult | 1 | 2017 | 2249 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2011 | 791 | 0.020 |
Why?
|
|
Peev's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|